Moudy Robin M, Ingerson-Mahar Michael, Kanter Jordan, Grant Ashley M, Fisher Dara R, Jones Franca R
Robin M. Moudy, PhD, and Ashley M. Grant, PhD, are AAAS Science and Technology Policy Fellows, Chemical and Biological Defense Program; Michael Ingerson-Mahar, PhD, is a AAAS Science and Technology Policy Fellow, Threat Reduction & Arms Control; and CDR Franca R. Jones, PhD, is Medical Director, Chemical and Biological Defense Program; all in the Office of the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense, Department of Defense, Washington, DC. Jordan Kanter is a master's student, Edmund A. Walsh School of Foreign Service, Georgetown University , Washington, DC. Dara Fisher is a doctoral student, Harvard Graduate School of Education, Cambridge, Massachusetts. The views presented here are those of the authors and do not necessarily represent those of the US Department of Defense.
Biosecur Bioterror. 2014 Sep-Oct;12(5):247-53. doi: 10.1089/bsp.2014.0055.
In 2011, President Obama addressed the United Nations General Assembly and urged the global community to come together to prevent, detect, and fight every kind of biological danger, whether a pandemic, terrorist threat, or treatable disease. Over the past decade, the United States and key international partners have addressed these dangers through a variety of programs and strategies aimed at developing and enhancing countries' capacity to rapidly detect, assess, report, and respond to acute biological threats. Despite our collective efforts, however, an increasingly interconnected world presents heightened opportunities for human, animal, and zoonotic diseases to emerge and spread globally. Further, the technical capabilities required to develop biological agents into a weapon are relatively low. The launch of the Global Health Security Agenda (GHSA) provides an opportunity for the international community to enhance the linkages between the health and security sectors, accelerating global efforts to prevent avoidable epidemics and bioterrorism, detect threats early, and respond rapidly and effectively to biological threats. The US Department of Defense (DoD) plays a key role in achieving GHSA objectives through its force health protection, threat reduction, and biodefense efforts at home and abroad. This article focuses on GHSA activities conducted in the DoD Office of the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense.
2011年，奥巴马总统在联合国大会上发表讲话，敦促全球社会团结起来，预防、发现并应对各类生物危险，无论是大流行病、恐怖主义威胁还是可治疗疾病。在过去十年里，美国和主要国际伙伴通过各种计划和战略应对这些危险，旨在发展和提高各国迅速发现、评估、报告及应对急性生物威胁的能力。然而，尽管我们共同努力，但日益相互关联的世界为人类、动物和人畜共患疾病的出现和全球传播带来了更多机会。此外，将生物制剂发展成武器所需的技术能力相对较低。全球卫生安全议程（GHSA）的启动为国际社会提供了一个机会，以加强卫生与安全部门之间的联系，加快全球努力预防可避免的流行病和生物恐怖主义，尽早发现威胁，并对生物威胁迅速做出有效应对。美国国防部通过其在国内外的部队健康保护、减少威胁和生物防御工作，在实现全球卫生安全议程目标方面发挥着关键作用。本文重点介绍在负责核、化学和生物防御的国防部助理部长办公室开展的全球卫生安全议程活动。
